Skip to main content
. 2019 Jun 20;40(5):1061–1076. doi: 10.1177/0271678X19858003

Figure 5.

Figure 5.

Increased levels of TSPO protein in putamen of patients with multiple system atrophy (MSA) as compared to control subjects. ***p < 0.001 (two-tailed t-test). Also shown are representative immunoblots of TSPO and an astroglial marker vimentin probed at the same time. Note greater increases in levels of vimentin as compared to that of TSPO in MSA (M1 and M2) versus controls (C1 and C2).